Citizens Reiterates Market Outperform on Kura Oncology, Maintains $24 Price Target
Kura Oncology Inc KURA
$9.93
▲ +3.76%
(+$0.36)
Open
$9.67
Prev Close
$9.57
Day Range
$9.55 – $9.98
52W Range
$5.45 – $12.49
Market Cap
$881.53M
Beta
0.38
EPS (TTM)
$-3.35
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2015-11-05 |
| Shares Out. | 88,770,000 |
| Website | kuraoncology.com/ ↗ |
| Phone | 13026587581 |
Kura Oncology Inc is a publicly traded company under the ticker symbol KURA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-06-01)
📰 Latest News for KURA
Kura Oncology, Inc. (KURA) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow
Kura Oncology, Inc. (KURA) Discusses Long-Term Results of Ziftomenib Combination Therapies in Newly Diagnosed and Relapsed/Refractory AML Transcript
Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
Kura Oncology And Kyowa Kirin Announce Long-Term Results From The Phase 1/2 KOMET-007 Single-Arm Trial Evaluating Ziftomenib In Combination With Intensive Chemotherapy
How The Kura Oncology (KURA) Investment Narrative Is Evolving Without New Analyst Revisions